D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Live Oak Bancshares
LOB
$1.69B
| $7.67M | 0.01% |
291,459
+38,025
| +15% | +$1M |
|
927
OptimizeRx
OPRX
$350M
| $7.66M | 0.01% |
535,979
+64,747
| +14% | +$925K |
|
928
FS KKR Capital
FSK
$4.99B
| $7.65M | 0.01% |
398,710
+135,164
| +51% | +$2.59M |
|
929
Dycom Industries
DY
$7.49B
| $7.64M | 0.01% |
67,229
-65,502
| -49% | -$7.44M |
|
|
THCP
930
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
| $7.64M | 0.01% |
754,821
| – | – |
|
931
Great Lakes Dredge & Dock
GLDD
$834M
| $7.62M | 0.01% |
934,374
-304,651
| -25% | -$2.49M |
|
932
iQIYI
IQ
$2.52B
| $7.62M | 0.01% |
1,426,815
+435,048
| +44% | +$2.32M |
|
933
Imperial Oil
IMO
$46.8B
| $7.61M | 0.01% |
148,690
-167,019
| -53% | -$8.54M |
|
934
Pliant Therapeutics
PLRX
$101M
| $7.59M | 0.01% |
418,663
-61,846
| -13% | -$1.12M |
|
|
CBAY
935
DELISTED
Cymabay Therapeutics
CBAY
| $7.58M | 0.01% |
692,401
+143,357
| +26% | +$1.57M |
|
936
Tigo Energy
TYGO
$116M
| $7.56M | 0.01% |
+407,475
| New | +$7.56M |
|
937
Metropolitan Bank Holding Corp
MCB
$823M
| $7.55M | 0.01% |
217,303
+40,701
| +23% | +$1.41M |
|
938
Braze
BRZE
$3.44B
| $7.53M | 0.01% |
172,070
+53,285
| +45% | +$2.33M |
|
939
AtriCure
ATRC
$1.87B
| $7.5M | 0.01% |
151,999
-26,828
| -15% | -$1.32M |
|
940
Eaton
ETN
$140B
| $7.5M | 0.01% |
37,282
+12,602
| +51% | +$2.53M |
|
941
Beazer Homes USA
BZH
$775M
| $7.5M | 0.01% |
264,945
+87,942
| +50% | +$2.49M |
|
942
Franco-Nevada
FNV
$38.9B
| $7.49M | 0.01% |
52,491
+31,555
| +151% | +$4.5M |
|
943
Rush Enterprises Class A
RUSHA
$4.48B
| $7.46M | 0.01% |
184,155
-13,143
| -7% | -$532K |
|
944
LoveSac
LOVE
$257M
| $7.42M | 0.01% |
275,279
-105,037
| -28% | -$2.83M |
|
945
Ryan Specialty Holdings
RYAN
$6.62B
| $7.41M | 0.01% |
165,033
-92,776
| -36% | -$4.16M |
|
946
Theravance Biopharma
TBPH
$690M
| $7.39M | 0.01% |
714,114
-300,879
| -30% | -$3.11M |
|
|
ICPT
947
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $7.39M | 0.01% |
667,979
+97,954
| +17% | +$1.08M |
|
948
Gannett
GCI
$632M
| $7.36M | 0.01% |
3,269,261
+2,568,192
| +366% | +$5.78M |
|
949
Blackstone Secured Lending
BXSL
$6.63B
| $7.35M | 0.01% |
268,616
-186,954
| -41% | -$5.12M |
|
950
Coca-Cola Europacific Partners
CCEP
$40.9B
| $7.35M | 0.01% |
114,005
-41,521
| -27% | -$2.68M |
|